Evidence map›Paper›PMID 38807989›Full record

ArticleFrontiers in public health2024

Sharing lessons learned from COVID-19 vaccine introductions: a global community forum for countries.

Jenny Anne Walldorf, Cindy Chiu De Vazquez, Ana Carolina Barbosa De Lima, Bruce Struminger, Amy Groom, Lauren Burke, Landry Ndriko Mayigane, Diana Chang Blanc, Liviu Vedrasco

Abstract read
In one paragraph

Article in Frontiers in public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jenny Anne Walldorf *Department of Immunization, Vaccines, and Biologicals, World Health Organization, Geneva, Switzerland.
Cindy Chiu De Vazquez *Department of Health Security Preparedness, World Health Organization, Geneva, Switzerland.
Ana Carolina Barbosa De LimaECHO Institute, University of New Mexico, Albuquerque, NM, United States.
Bruce StrumingerECHO Institute, University of New Mexico, Albuquerque, NM, United States.
Amy GroomECHO Institute, University of New Mexico, Albuquerque, NM, United States.
Lauren BurkeECHO Institute, University of New Mexico, Albuquerque, NM, United States.
Landry Ndriko MayiganeDepartment of Health Security Preparedness, World Health Organization, Geneva, Switzerland.
Diana Chang BlancDepartment of Immunization, Vaccines, and Biologicals, World Health Organization, Geneva, Switzerland.
Liviu VedrascoDepartment of Health Security Preparedness, World Health Organization, Geneva, Switzerland.

Funding

World Health Organization 001
6 · The paper itself

Abstract

To optimize the efficient introduction and deployment of COVID-19 vaccines across the globe during the COVID-19 pandemic, in April 2021 WHO launched a new process and tools for countries to rapidly review the early phase of countries' COVID-19 vaccine introduction. This methodology is called the COVID-19 vaccination intra-action review, also known as mini COVID-19 vaccine post-introduction evaluation (mini-cPIE). As of November 2022, 46 mini-cPIEs had been conducted. In collaboration with Project ECHO, WHO convened and facilitated real-time experience sharing and peer-learning among countries following their mini-cPIEs through a virtual global real-time learning forum. This five-session clinic series was attended by 736 participants from 129 countries. Based on post-session feedback surveys, when asked about the utility of the sessions, half of the participants said that sessions led them to review national guidelines and protocols or make other changes to their health systems. The post-series survey sent following the end of the clinic series showed that at least eight countries subsequently conducted a mini-cPIE after participating in the clinics, and participants from at least nine countries indicated the experience shared by peer countries on the clinic largely benefited their COVID-19 vaccine introduction and deployment. In this article, we highlight the benefits and importance of creating a global experience-sharing forum for countries to connect and share pertinent learnings in real-time during an international public health emergency. Moving forward, it is critical to foster a culture of individual and collective learning within and between countries during public health emergencies, with WHO playing an important convening role.

Indexed as

COVID-19COVID-19 VaccinesGlobal HealthHumansPandemicsSARS-CoV-2World Health OrganizationCOVID-19 Vaccinescommunity of practiceCOVID-19emergenciesimmunizationprogram evaluation

Identifiers

PMID38807989
PMCPMC11130350

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.